Xellar Biosystems is a Wet Artificial Intelligence (AI) biotechnology company, combining machine learning and AI with large-scale wet-lab experiments, tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.
Location: United States
Total raised: $50M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.07.2026 | Series A | $50M | - |
Mentions in press and media 6
| Date | Title | Description |
| 08.07.2026 | Xellar Biosystems Secures $50M. AI-Driven 3D Bio Intelligence Emerges. | Xellar Biosystems secured $50 million in Series A and A+ funding. This Boston biotech company pioneers AI-driven 3D Bio Intelligence. It uses Organ-on-a-Chip technology. Realistic human tissue models accelerate drug discovery. The platform ... |
| 02.07.2026 | Xellar Biosystems Raises $50M in Series A and A+ Financing | Xellar Biosystems, a Boston, MA-based AI-driven biotech company advancing a 3D Bio Intelligence platform, raised $50M in Series A and A+ financing. Backers were not disclosed. Founded in 2022 and led by Xin Xie, PhD, CEO, Xellar Biosystems ... |
| 30.06.2026 | Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence | Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery BOSTON, June 30, 2026 /PRNewswire/ -- Xellar Biosystems today announced the closing of... |
| 23.07.2024 | Xellar Biosystems raises angel+ round and 40 other Greater China deals worth over $431m | Xellar Biosystems, an artificial intelligence (AI) biotech firm that combines machine learning and AI with large-scale wet-lab experiments, has secured 100 million yuan ($14 million) in its angel+ funding round led by Chinese pharmaceutical... |
| 17.07.2024 | Deals in brief: East Ventures leads investment in Har Har Chicken, Wittaya Aqua reels in USD 2.8 million, Mon Protocol launches new venture with 500 Global, and more | East Ventures leads investment in Singapore-based Har Har Chicken Har Har Chicken, a takeaway kiosk operator serving specialty menu items inspired by fermented prawn paste chicken, has raised an undisclosed amount of funding in a round led ... |
| - | Xellar Biosystems | “Xellar Biosystems is a Wet Artificial Intelligence (AI) biotechnology company, combining machine learning and AI with large-scale wet-lab experiments, tackling the most challenging problem in modern drug discovery – harnessing the complexi... |